MESOBLAST : Reports Strong Financial Position and Substantial Operational Progress For the Period Ended March 31, 2020
MarketScreener,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…